Neuropsychiatric events during prophylactic use of mefloquine before travelling

被引：0
|
作者：
M. van Riemsdijk
J. Ditters
M. Sturkenboom
J. Tulen
R. Ligthelm
D. Overbosch
B. Stricker
机构：
[1] Department of Epidemiology and Biostatistics,
[2] Erasmus MC,undefined
[3] Grasmus University Rotterdam,undefined
[4] PO Box 1738,undefined
[5] 3000 DR Rotterdam,undefined
[6] the Netherlands,undefined
[7] Department of Pharmacotherapy and Pharmacoepidemiology,undefined
[8] Utrecht University,undefined
[9] Utrecht,undefined
[10] the Netherlands,undefined
[11] Department of Psychiatry,undefined
[12] Erasmus MC,undefined
[13] Grasmus University Rotterdam,undefined
[14] Rotterdam,undefined
[15] the Netherlands,undefined
[16] Travel Clinic,undefined
[17] Havenziekenhuis and Institute for Tropical Diseases,undefined
[18] Rotterdam,undefined
[19] the Netherlands,undefined
来源：
European Journal of Clinical Pharmacology | 2002年 / 58卷
关键词：
Neuropsychiatric events Prophylaxis Mefloquine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Abstract
引用
收藏
页码：441 / 445
页数：4
相关论文
共 50 条
  • [1] Neuropsychiatric events during prophylactic use of mefloquine before travelling
    van Riemsdijk, MM
    Ditters, JM
    Sturkenboom, MCJM
    Tulen, JHM
    Ligthelm, RJ
    Overbosch, D
    Stricker, BHC
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (06) : 441 - 445
  • [2] Neuropsychiatric adverse events during prophylaxis against malaria by using mefloquine before traveling
    Al-Amer, Osama
    ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2015, 8 (05) : 159 - 163
  • [3] Adverse neuropsychiatric events common with mefloquine
    Reactions Weekly, 2002, 924 (1) : 5 - 5
  • [4] EXACERBATION OF EPILEPSY DURING PROPHYLACTIC TREATMENT WITH MEFLOQUINE
    BESSER, R
    KRAMER, G
    NERVENARZT, 1991, 62 (12): : 760 - 761
  • [5] NEUROPSYCHIATRIC SIDE-EFFECTS AFTER THE USE OF MEFLOQUINE
    WEINKE, T
    TRAUTMANN, M
    HELD, T
    WEBER, G
    EICHENLAUB, D
    FLEISCHER, K
    KERN, W
    POHLE, HD
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1991, 45 (01): : 86 - 91
  • [6] Mefloquine concentration profiles during prophylactic dose regimens
    Kollaritsch, H
    Karbwang, J
    Wiedermann, G
    Mikolasek, A
    Na-Bangchang, K
    Wernsdorfer, WH
    WIENER KLINISCHE WOCHENSCHRIFT, 2000, 112 (10) : 441 - 447
  • [7] Adverse events associated with prophylactic corticosteroid use before extubation: a cohort study
    Kuriyama, Akira
    Egawa, Satoshi
    Kataoka, Jun
    Sakuraya, Masaaki
    Matsumura, Masami
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (14)
  • [8] Signal detection to identify serious adverse events (neuropsychiatric events) in travelers taking mefloquine for chemoprophylaxis of malaria
    Naing, Cho
    Aung, Kyan
    Ahmed, Syed Imran
    Mak, Joon Wah
    DRUG HEALTHCARE AND PATIENT SAFETY, 2012, 4 : 87 - 92
  • [9] Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: A focus on neuropsychiatric adverse events
    van Riemsdijk, MM
    Sturkenboom, MCJM
    Ditters, JM
    Ligthelm, RJ
    Overbosch, D
    Stricker, BHC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (03) : 294 - 301
  • [10] Post-marketing surveillance of prophylactic mefloquine (Lariam®) use in pregnancy
    Vanhauwere, B
    Maradit, H
    Kerr, L
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (01): : 17 - 21
12345